Experts Say Erectile Dysfunction Drugs, Like Viagra, Could Decrease Men's Risk Of Heart Attack

A new research from Sweden recently discovered that taking drugs for erectile dysfunction (ED) could decrease the risk for heart attacks and prevent heart failure. Scientists found that men who were taking Phosphodiesterase-5 (PDE-5) inhibitors, such as Viagra, Cialis, Levitra, and Spedra, are unlikely to die prematurely after experiencing their first heart attack. Not only it boosts a man's sexual activity, it also establishes a healthy heart, the Mirror stated.

In a report by Men's Health, the study observed 43,000 Swedish men who are at the age of 80 years old or went through a first heart attack from 2007 to 2013. 7% of these patients were prescribed with erectile dysfunction meds. Apparently, men who were given treatment for ED were 40% less likely to suffer from heart failure. Meanwhile, 33% of them were unlikely to die at the time of their follow-up at any cause.

To explicit the outcome of the treatment, only those who received erectile dysfunction meds orally were likely to live longer. However, patients receiving PDE-5 inhibitors post heart attack were 38% less likely to die during follow-up than men who aren't receiving alprostadil. There was no evident connection between the use of alprostadil, an injectable type of ED drug like Muse, and premature death risk, Health 24 stated.

Though recent studies showed the benefits obtained from PDE-5 inhibitors, previous study plan facilitated in verifying its cause and effect. Originally, this drug is generated for angina, a condition caused by narrowed arteries which result in chest pain. PDE-5 inhibitors, according to previous research, decreases blood pleasure in the left ventricle. It eventually lessens the workload of the heart which can conclude to its significant effect to individuals with heart failure. However, some experts still consider that active sex life might help explain the early death-erectile dysfunction meds link, leading them to a decision of conducting further research for clarifications.